Skip to search formSkip to main content

Stem Cell Mobilization Therapy

Known as: Mobilization Therapy 
Therapy to cause release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of collection.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with…
BACKGROUND High-dose thiotepa, busulfan, and cyclophosphamide (TBC) with autologous stem cell transplantation (ASCT) has been… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2011
Review
2011
The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation 
  • figure 1
  • table 1
  • table 2
Is this relevant?
2009
2009
Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian…
CD34+ peripheral blood hematopoietic stem cells (HSC) are usually collected following mobilization therapy accomplished by using… Expand
Is this relevant?
2008
2008
Lung insufflation capacity in neuromuscular disease.
OBJECTIVE To compare maximal passive lung insufflation capacity (LIC) with lung inflation by air stacking (to maximum… Expand
  • figure 1
  • figure 2
Is this relevant?
2007
2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
In a phase III randomized, multicenter study, the German-speaking Myeloma-Multicenter Group (GMMG) and the Dutch-Belgian Hemato… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution.
Acute renal failure and tubular cell loss as a result of ischemia constitute major challenges in renal pathophysiology… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Fibroblast responses to variation in soft tissue mobilization pressure.
UNLABELLED Augmented soft tissue mobilization therapy (ASTM), a newly developed massage therapy, has been successfully used in… Expand
Is this relevant?
1998
1998
Effective mobilization of Philadelphia-chromosome-negative cells in chronic myelogenous leukaemia patients using a less intensive regimen.
To determine if reducing the intensity of the mobilizing chemotherapy protocol used would alter the number and/or quality of the… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.
The purpose of this study was to compare the ability to collect human bone marrow-derived mesenchymal (stromal) progenitor cells… Expand
Is this relevant?
1996
1996
When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood.
PURPOSE To evaluate whether the CD34+ yield from a single peripheral-blood stem-cell (PBSC) harvest could be predicted by… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE